Published in Ann Intern Med on December 21, 2010
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS (2011) 3.39
The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med (2012) 2.34
HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS (2012) 1.97
Test-and-treat in Los Angeles: a mathematical model of the effects of test-and-treat for the population of men who have sex with men in Los Angeles County. Clin Infect Dis (2013) 1.77
Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS (2012) 1.73
The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States. Clin Infect Dis (2015) 1.69
Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study. Lancet HIV (2015) 1.53
Effect of the US National HIV/AIDS Strategy targets for improved HIV care engagement: a modelling study. Lancet HIV (2016) 1.51
A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PLoS One (2012) 1.50
Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health. Am J Public Health (2012) 1.34
HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions. PLoS Med (2012) 1.29
Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med (2013) 1.28
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One (2014) 1.25
Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children. AIDS (2013) 1.21
The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. AIDS (2011) 1.14
HIV treatment as prevention: issues in economic evaluation. PLoS Med (2012) 1.10
The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008. PLoS One (2011) 1.09
Averting HIV infections in New York City: a modeling approach estimating the future impact of additional behavioral and biomedical HIV prevention strategies. PLoS One (2013) 1.07
The cost-effectiveness of a modestly effective HIV vaccine in the United States. Vaccine (2011) 1.06
Responding to the National HIV/AIDS Strategy-setting the research agenda. J Acquir Immune Defic Syndr (2011) 1.02
HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation. PLoS Med (2012) 0.99
HIV-1 disease progression during highly active antiretroviral therapy: an application using population-level data in British Columbia: 1996-2011. J Acquir Immune Defic Syndr (2013) 0.96
Cost-effectiveness of antiretroviral therapy for prevention. Curr HIV Res (2011) 0.95
HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis. PLoS One (2011) 0.94
Indices to measure risk of HIV acquisition in Rakai, Uganda. PLoS One (2014) 0.94
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006. PLoS One (2011) 0.93
Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction (2015) 0.92
Projecting HIV transmission in Japan. PLoS One (2012) 0.91
Newly identified HIV infections in correctional facilities, United States, 2007. Am J Public Health (2012) 0.89
Economic and epidemiological impact of early antiretroviral therapy initiation in India. J Int AIDS Soc (2015) 0.88
The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis. AIDS (2011) 0.86
Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009. Health Aff (Millwood) (2014) 0.85
Modeling the impact of interventions along the HIV continuum of care in Newark, New Jersey. Clin Infect Dis (2013) 0.85
HIV epidemic control-a model for optimal allocation of prevention and treatment resources. Health Care Manag Sci (2013) 0.84
Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom. PLoS One (2014) 0.84
Mathematical models for the study of HIV spread and control amongst men who have sex with men. Eur J Epidemiol (2011) 0.84
Costs of health resource utilization among HIV-positive individuals in British Columbia, Canada: results from a population-level study. Pharmacoeconomics (2015) 0.83
Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States. Ann Intern Med (2016) 0.80
Optimizing an HIV testing program using a system dynamics model of the continuum of care. Health Care Manag Sci (2015) 0.78
HIV testing and engagement in care among highly vulnerable female sex workers: implications for treatment as prevention models. J Health Care Poor Underserved (2014) 0.78
Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States. PLoS One (2015) 0.77
Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China. PLoS One (2016) 0.75
HIV treatment as prevention: contradictory perspectives from dynamic mathematical models. ScientificWorldJournal (2014) 0.75
Assessment and improvement of HIV screening rates in a Midwest primary care practice using an electronic clinical decision support system: a quality improvement study. BMC Med Inform Decis Mak (2016) 0.75
Internet use associated with HIV testing in adults in a national sample: Findings from the National Health Interview Survey, 2009. Prev Med Rep (2014) 0.75
Modeling the cost-effectiveness of health programs: HIV testing and early treatment in the USA. Future Microbiol (2011) 0.75
Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study. PLoS One (2015) 0.75
"Know Your Status": results from a novel, student-run HIV testing initiative on college campuses. AIDS Educ Prev (2014) 0.75
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28
Estimation of HIV incidence in the United States. JAMA (2008) 21.27
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr (2005) 15.14
Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet (2001) 13.31
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA (2004) 10.40
Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med (2005) 8.49
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med (2005) 7.98
Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA (1991) 7.35
Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med (2007) 7.14
HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57
Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol (1999) 6.25
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
The lifetime cost of current human immunodeficiency virus care in the United States. Med Care (2006) 5.87
Relation between HIV viral load and infectiousness: a model-based analysis. Lancet (2008) 5.74
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med (2006) 5.62
Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet (2004) 5.57
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med (2006) 5.53
Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr (2005) 4.96
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (2000) 4.91
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86
Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr (1994) 4.81
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS (2004) 4.64
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46
Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med (2008) 4.28
Associations of race/ethnicity with HIV prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States. J Acquir Immune Defic Syndr (2004) 4.25
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ (2002) 3.70
Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 3.67
Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol (1997) 3.66
Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med (2001) 3.64
Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. JAMA (2008) 3.61
The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. Science (1998) 3.60
Discordance between sexual behavior and self-reported sexual identity: a population-based survey of New York City men. Ann Intern Med (2006) 3.51
Sex hustling, injection drug use, and non-gay identification by men who have sex with men. Associations with high-risk sexual behaviors and condom use. Sex Transm Dis (1998) 3.21
Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med (1998) 3.14
Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med (2004) 3.06
The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology (1994) 3.05
Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health (2003) 3.03
Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health (2004) 2.93
How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission? AIDS (2007) 2.77
Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA (2006) 2.53
Late HIV testing - 34 states, 1996-2005. MMWR Morb Mortal Wkly Rep (2009) 2.53
A meta-analysis of utility estimates for HIV/AIDS. Med Decis Making (2002) 2.12
Persons tested for HIV--United States, 2006. MMWR Morb Mortal Wkly Rep (2008) 2.08
Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 2.00
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Med Decis Making (2002) 1.94
Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect (2002) 1.81
HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco. J Urban Health (2005) 1.77
HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health (2000) 1.74
The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr (2006) 1.71
Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis (2007) 1.70
Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. J Gen Intern Med (2008) 1.67
A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr (1992) 1.65
Probabilities of sexual HIV-1 transmission. AIDS (1996) 1.64
Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings. J Acquir Immune Defic Syndr (2006) 1.62
Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med (2005) 1.56
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia. AIDS (2006) 1.48
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis (2007) 1.43
Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis (2006) 1.43
Behavior changes after notification of HIV infection. Am J Public Health (1991) 1.38
Modeling HIV infectivity: must sex acts be counted? J Acquir Immune Defic Syndr (1990) 1.33
Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health (2009) 1.29
Lessons learned about behavioral science and acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: V. AIDS Behav (2009) 1.26
Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I. AIDS Behav (2009) 1.26
Unintentional HIV exposures from young men who have sex with men who disclose being HIV-negative. AIDS (2006) 1.24
Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med (2008) 1.23
Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update. AIDS (2009) 1.22
The effect of diagnosis with HIV infection on health-related quality of Life. Qual Life Res (2006) 1.18
HIV transmission under highly active antiretroviral therapy. Lancet (2008) 1.17
Screening women of childbearing age for human immunodeficiency virus. A cost-benefit analysis. Arch Intern Med (1992) 1.13
Male homosexual transmission of HIV-1. AIDS (1994) 1.12
Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV. Am J Public Health (2007) 1.10
Cost-effectiveness of HIV screening in acute care settings. Arch Intern Med (1996) 1.05
Highlights of the sexual activity of the heterosexual population in the province of Quebec. Sex Transm Infect (1999) 1.02
Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial. J Gen Intern Med (2010) 1.01
United States life tables, 2005. Natl Vital Stat Rep (2010) 1.01
Potential population health outcomes and expenditures of HIV vaccination strategies in the United States. Vaccine (2009) 1.01
Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis. J Acquir Immune Defic Syndr (2009) 0.99
Severe illness and death among injecting drug users in Scotland: a case-control study. Epidemiol Infect (2005) 0.92
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease. J Acquir Immune Defic Syndr (2009) 0.91
The role of sexually transmitted infections in male circumcision effectiveness against HIV--insights from clinical trial simulation. Emerg Themes Epidemiol (2006) 0.90
Drug use and sexual behaviors reported by adults: United States, 1999-2002. Adv Data (2007) 0.89
Efficient allocation of resources to prevent HIV infection among injection drug users: the Prevention Point Philadelphia (PPP) needle exchange program. Health Econ (2006) 0.86
AIDS risk and risk reduction in the radiology department. AJR Am J Roentgenol (1991) 0.83
Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med (2007) 9.88
Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA (2006) 9.36
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med (2005) 7.98
Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med (2005) 7.46
Are organic foods safer or healthier than conventional alternatives?: a systematic review. Ann Intern Med (2012) 5.45
Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med (2010) 5.14
Systematic review: surveillance systems for early detection of bioterrorism-related diseases. Ann Intern Med (2004) 4.58
Quality improvement strategies for hypertension management: a systematic review. Med Care (2006) 4.29
Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med (2008) 4.28
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med (2010) 4.16
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med (2003) 3.88
Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society. Spine (Phila Pa 1976) (2009) 3.45
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med (2007) 3.17
Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2007) 3.14
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med (2007) 3.10
Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med (2007) 3.03
Systematic review: elective induction of labor versus expectant management of pregnancy. Ann Intern Med (2009) 3.01
Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. Arch Intern Med (2008) 2.96
Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis. Am J Med (2004) 2.89
Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med (2006) 2.80
Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from theAmerican College of Physicians. Ann Intern Med (2014) 2.75
Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 2.69
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2007) 2.69
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Ann Intern Med (2014) 2.69
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med (2011) 2.68
Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med (2006) 2.49
The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med (2012) 2.34
Diagnostic imaging for low back pain: advice for high-value health care from the American College of Physicians. Ann Intern Med (2011) 2.29
Cost-effectiveness of elective induction of labor at 41 weeks in nulliparous women. Am J Obstet Gynecol (2010) 2.22
Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms. Ann Emerg Med (2010) 2.19
Models in the development of clinical practice guidelines. Ann Intern Med (2014) 2.18
Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2013) 2.05
Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Circulation (2010) 2.00
Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 1.98
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis. Ann Intern Med (2012) 1.96
Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 1.92
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. Value Health (2012) 1.90
Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 1.83
Evaluation of primary care patients with chronic stable angina: guidelines from the American College of Physicians. Ann Intern Med (2004) 1.78
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med (2007) 1.76
The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med (2010) 1.76
Cost-effectiveness of helicopter versus ground emergency medical services for trauma scene transport in the United States. Ann Emerg Med (2013) 1.74
Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Fam Med (2007) 1.72
Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax. Ann Intern Med (2005) 1.69
Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med (2009) 1.68
Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2013) 1.68
Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. J Gen Intern Med (2008) 1.67
Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. JACC Cardiovasc Interv (2008) 1.66
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med (2008) 1.65
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med (2003) 1.63
Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. PLoS Med (2011) 1.62
Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med (2003) 1.61
Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator. Health Aff (Millwood) (2005) 1.60
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Fam Med (2007) 1.54
Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review. PLoS One (2013) 1.49
Maternal and neonatal outcomes of elective induction of labor. Evid Rep Technol Assess (Full Rep) (2009) 1.49
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia. AIDS (2006) 1.48
Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2004) 1.45
Implementing effective hypertension quality improvement strategies: barriers and potential solutions. J Clin Hypertens (Greenwich) (2008) 1.44
Comparative effectiveness of HIV testing and treatment in highly endemic regions. Arch Intern Med (2010) 1.41
Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure. Ann Intern Med (2015) 1.39
Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med (2003) 1.33
Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med (2009) 1.33
Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2009) 1.30
Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med (2013) 1.27
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making (2012) 1.24
Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med (2008) 1.23
Challenges in systematic reviews: synthesis of topics related to the delivery, organization, and financing of health care. Ann Intern Med (2005) 1.20
Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis. AIDS (2011) 1.18
The effect of diagnosis with HIV infection on health-related quality of Life. Qual Life Res (2006) 1.18
Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis. Ann Intern Med (2006) 1.17
Evaluating detection of an inhalational anthrax outbreak. Emerg Infect Dis (2006) 1.17
The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. AIDS (2011) 1.14
Evaluating detection and diagnostic decision support systems for bioterrorism response. Emerg Infect Dis (2004) 1.13
Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology (2010) 1.07
The cost-effectiveness of a modestly effective HIV vaccine in the United States. Vaccine (2011) 1.06
Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Clin Infect Dis (2010) 1.06
Quality improvement strategies for children with asthma: a systematic review. Arch Pediatr Adolesc Med (2009) 1.06
A little planning goes a long way: multilevel allocation of HIV prevention resources. Med Decis Making (2007) 1.04
Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis. PLoS Med (2012) 1.04
Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice. Med Decis Making (2010) 1.04
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol (2013) 1.03
Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2005) 1.03
Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users. PLoS One (2012) 1.03
Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med (2007) 1.03
Dynamic resource allocation for epidemic control in multiple populations. IMA J Math Appl Med Biol (2002) 1.02
The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Arch Intern Med (2006) 1.02
Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial. J Gen Intern Med (2010) 1.01
Potential population health outcomes and expenditures of HIV vaccination strategies in the United States. Vaccine (2009) 1.01